Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder

Applications of a proteomic informed genomic approach

Malik Nassan, Yun Fang Jia, Greg Jenkins, Colin Colby, Scott Feeder, Doo Sup Choi, Marin D Veldic, Susan L. McElroy, David J. Bond, Richard M Weinshilboum, Joanna M Biernacka, Mark A Frye

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In a prior discovery study, increased levels of serum Growth Differentiation Factor 15 (GDF15), Hepsin (HPN), and Matrix Metalloproteinase-7 (MMP7) were observed in bipolar depressed patients vs controls. This exploratory post-hoc analysis applied a proteomic-informed genomic research strategy to study the potential functional role of these proteins in bipolar disorder (BP). Utilizing the Genotype-Tissue Expression (GTEx) database to identify cis-acting blood expression quantitative trait loci (cis-eQTLs), five eQTL variants from the HPN gene were analyzed for association with BP cases using genotype data of cases from the discovery study (n = 58) versus healthy controls (n = 777). After adjusting for relevant covariates, we analyzed the relationship between these 5 cis-eQTLs and HPN serum level in the BP cases. All 5 cis-eQTL minor alleles were significantly more frequent in BP cases vs controls [(rs62122114, OR = 1.6, p = 0.02), (rs67003112, OR = 1.6, p = 0.02), (rs4997929, OR = 1.7, p = 0.01), (rs12610663, OR = 1.7, p = 0.01), (rs62122148, OR = 1.7, P = 0.01)]. The minor allele (A) in rs62122114 was significantly associated with increased serum HPN level in BP cases (Beta = 0.12, P = 0.049). However, this same minor allele was associated with reduced gene expression in GTEx controls. These exploratory analyses suggest that genetic variation in/near the gene encoding for hepsin protein may influence risk of bipolar disorder. This genetic variation, at least for the rs62122114-A allele, may have functional impact (i.e. differential expression) as evidenced by serum HPN protein expression. Although limited by small sample size, this study highlights the merits of proteomic informed functional genomic studies as a tool to investigate with greater precision the genetic risk of bipolar disorder and secondary relationships to protein expression recognizing, and encouraging in subsequent studies, high likelihood of epigenetic modification of genetic disease risk.

Original languageEnglish (US)
Pages (from-to)208-212
Number of pages5
JournalJournal of Psychiatric Research
Volume95
DOIs
StatePublished - Dec 1 2017

Fingerprint

Bipolar Disorder
Proteomics
Quantitative Trait Loci
Alleles
Proteins
Genotype
Growth Differentiation Factor 15
Serum
Matrix Metalloproteinase 7
Inborn Genetic Diseases
hepsin
Protein
Epigenomics
Sample Size
Genes
Blood Proteins
Databases
Gene Expression
Allele
Research

Keywords

  • Bipolar disorder
  • Growth differentiation factor 15 (GDF15)
  • Hepsin (HPN)
  • Matrix Metalloproteinase-7 (MMP7)
  • Proteomic profile

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder : Applications of a proteomic informed genomic approach. / Nassan, Malik; Jia, Yun Fang; Jenkins, Greg; Colby, Colin; Feeder, Scott; Choi, Doo Sup; Veldic, Marin D; McElroy, Susan L.; Bond, David J.; Weinshilboum, Richard M; Biernacka, Joanna M; Frye, Mark A.

In: Journal of Psychiatric Research, Vol. 95, 01.12.2017, p. 208-212.

Research output: Contribution to journalArticle

@article{5aeb0d4c3272401fb35ae95738018fcb,
title = "Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach",
abstract = "In a prior discovery study, increased levels of serum Growth Differentiation Factor 15 (GDF15), Hepsin (HPN), and Matrix Metalloproteinase-7 (MMP7) were observed in bipolar depressed patients vs controls. This exploratory post-hoc analysis applied a proteomic-informed genomic research strategy to study the potential functional role of these proteins in bipolar disorder (BP). Utilizing the Genotype-Tissue Expression (GTEx) database to identify cis-acting blood expression quantitative trait loci (cis-eQTLs), five eQTL variants from the HPN gene were analyzed for association with BP cases using genotype data of cases from the discovery study (n = 58) versus healthy controls (n = 777). After adjusting for relevant covariates, we analyzed the relationship between these 5 cis-eQTLs and HPN serum level in the BP cases. All 5 cis-eQTL minor alleles were significantly more frequent in BP cases vs controls [(rs62122114, OR = 1.6, p = 0.02), (rs67003112, OR = 1.6, p = 0.02), (rs4997929, OR = 1.7, p = 0.01), (rs12610663, OR = 1.7, p = 0.01), (rs62122148, OR = 1.7, P = 0.01)]. The minor allele (A) in rs62122114 was significantly associated with increased serum HPN level in BP cases (Beta = 0.12, P = 0.049). However, this same minor allele was associated with reduced gene expression in GTEx controls. These exploratory analyses suggest that genetic variation in/near the gene encoding for hepsin protein may influence risk of bipolar disorder. This genetic variation, at least for the rs62122114-A allele, may have functional impact (i.e. differential expression) as evidenced by serum HPN protein expression. Although limited by small sample size, this study highlights the merits of proteomic informed functional genomic studies as a tool to investigate with greater precision the genetic risk of bipolar disorder and secondary relationships to protein expression recognizing, and encouraging in subsequent studies, high likelihood of epigenetic modification of genetic disease risk.",
keywords = "Bipolar disorder, Growth differentiation factor 15 (GDF15), Hepsin (HPN), Matrix Metalloproteinase-7 (MMP7), Proteomic profile",
author = "Malik Nassan and Jia, {Yun Fang} and Greg Jenkins and Colin Colby and Scott Feeder and Choi, {Doo Sup} and Veldic, {Marin D} and McElroy, {Susan L.} and Bond, {David J.} and Weinshilboum, {Richard M} and Biernacka, {Joanna M} and Frye, {Mark A}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.jpsychires.2017.07.005",
language = "English (US)",
volume = "95",
pages = "208--212",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder

T2 - Applications of a proteomic informed genomic approach

AU - Nassan, Malik

AU - Jia, Yun Fang

AU - Jenkins, Greg

AU - Colby, Colin

AU - Feeder, Scott

AU - Choi, Doo Sup

AU - Veldic, Marin D

AU - McElroy, Susan L.

AU - Bond, David J.

AU - Weinshilboum, Richard M

AU - Biernacka, Joanna M

AU - Frye, Mark A

PY - 2017/12/1

Y1 - 2017/12/1

N2 - In a prior discovery study, increased levels of serum Growth Differentiation Factor 15 (GDF15), Hepsin (HPN), and Matrix Metalloproteinase-7 (MMP7) were observed in bipolar depressed patients vs controls. This exploratory post-hoc analysis applied a proteomic-informed genomic research strategy to study the potential functional role of these proteins in bipolar disorder (BP). Utilizing the Genotype-Tissue Expression (GTEx) database to identify cis-acting blood expression quantitative trait loci (cis-eQTLs), five eQTL variants from the HPN gene were analyzed for association with BP cases using genotype data of cases from the discovery study (n = 58) versus healthy controls (n = 777). After adjusting for relevant covariates, we analyzed the relationship between these 5 cis-eQTLs and HPN serum level in the BP cases. All 5 cis-eQTL minor alleles were significantly more frequent in BP cases vs controls [(rs62122114, OR = 1.6, p = 0.02), (rs67003112, OR = 1.6, p = 0.02), (rs4997929, OR = 1.7, p = 0.01), (rs12610663, OR = 1.7, p = 0.01), (rs62122148, OR = 1.7, P = 0.01)]. The minor allele (A) in rs62122114 was significantly associated with increased serum HPN level in BP cases (Beta = 0.12, P = 0.049). However, this same minor allele was associated with reduced gene expression in GTEx controls. These exploratory analyses suggest that genetic variation in/near the gene encoding for hepsin protein may influence risk of bipolar disorder. This genetic variation, at least for the rs62122114-A allele, may have functional impact (i.e. differential expression) as evidenced by serum HPN protein expression. Although limited by small sample size, this study highlights the merits of proteomic informed functional genomic studies as a tool to investigate with greater precision the genetic risk of bipolar disorder and secondary relationships to protein expression recognizing, and encouraging in subsequent studies, high likelihood of epigenetic modification of genetic disease risk.

AB - In a prior discovery study, increased levels of serum Growth Differentiation Factor 15 (GDF15), Hepsin (HPN), and Matrix Metalloproteinase-7 (MMP7) were observed in bipolar depressed patients vs controls. This exploratory post-hoc analysis applied a proteomic-informed genomic research strategy to study the potential functional role of these proteins in bipolar disorder (BP). Utilizing the Genotype-Tissue Expression (GTEx) database to identify cis-acting blood expression quantitative trait loci (cis-eQTLs), five eQTL variants from the HPN gene were analyzed for association with BP cases using genotype data of cases from the discovery study (n = 58) versus healthy controls (n = 777). After adjusting for relevant covariates, we analyzed the relationship between these 5 cis-eQTLs and HPN serum level in the BP cases. All 5 cis-eQTL minor alleles were significantly more frequent in BP cases vs controls [(rs62122114, OR = 1.6, p = 0.02), (rs67003112, OR = 1.6, p = 0.02), (rs4997929, OR = 1.7, p = 0.01), (rs12610663, OR = 1.7, p = 0.01), (rs62122148, OR = 1.7, P = 0.01)]. The minor allele (A) in rs62122114 was significantly associated with increased serum HPN level in BP cases (Beta = 0.12, P = 0.049). However, this same minor allele was associated with reduced gene expression in GTEx controls. These exploratory analyses suggest that genetic variation in/near the gene encoding for hepsin protein may influence risk of bipolar disorder. This genetic variation, at least for the rs62122114-A allele, may have functional impact (i.e. differential expression) as evidenced by serum HPN protein expression. Although limited by small sample size, this study highlights the merits of proteomic informed functional genomic studies as a tool to investigate with greater precision the genetic risk of bipolar disorder and secondary relationships to protein expression recognizing, and encouraging in subsequent studies, high likelihood of epigenetic modification of genetic disease risk.

KW - Bipolar disorder

KW - Growth differentiation factor 15 (GDF15)

KW - Hepsin (HPN)

KW - Matrix Metalloproteinase-7 (MMP7)

KW - Proteomic profile

UR - http://www.scopus.com/inward/record.url?scp=85028694472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028694472&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2017.07.005

DO - 10.1016/j.jpsychires.2017.07.005

M3 - Article

VL - 95

SP - 208

EP - 212

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -